• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

DDI - REMS Webinar - October 24, 2011

 
The Food and Drug Administration, Center for Drug Evaluation and Research (CDER), is delighted to inform you of a unique opportunity for healthcare professionals, pharmacy students, nurse practitioner students and medical students in the United States to learn more about the FDA and drug regulation. CDER's Division of Drug Information (DDI) is offering a series of educational webinars, developed by FDA pharmacists and targeted to the needs of all healthcare professionals and students.
 
These focused webinars support FDA's mission of promoting and protecting public health, through interaction and education to strengthen relationships with future clinicians, researchers, nurses, and pharmacists. Fostering this connection will provide a better understanding of FDA's role in public health as a regulatory agency.
 
On October 24, 2011, CDER's Office of Communication, Division of Drug Information (DDI) presented a webinar titled, "Risk Evaluation and Mitigation Strategies (REMS)". Lena Y. Choe, Pharm.D., presented information regarding the Food and Drug Administration Amendments Act (FDAAA) of 2007, FDA authorities under FDAAA, and the possible elements to REMS.
 

 


 

If you've never used Connect Pro, get a quick overview:

http://www.adobe.com/go/connectpro_overview
Test your connection prior to the day of the event:
https://collaboration.fda.gov/common/help/en/support/meeting_test.htm
 
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.